Related references
Note: Only part of the references are listed.ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus
Nicholas J. Shaheen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis
Ian L. P. Beales et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Development and Validation of a Prediction Model Associated with Neoplastic Progression of Barrett's Esophagus (BE): Data from a Multi-Center Prospective Cohort
Sravanthi Parasa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma
Thomas M. Runge et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2015)
Androgens and esophageal cancer: What do we know?
Olga A. Sukocheva et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008)
L. N. Mathieu et al.
DISEASES OF THE ESOPHAGUS (2014)
Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus
Piers Gatenby et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Risk Factors in the Development of Esophageal Adenocarcinoma
Heiko Pohl et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells
O. A. Sukocheva et al.
DISEASES OF THE ESOPHAGUS (2013)
A Second-Generation 2-Methoxyestradiol Prodrug Is Effective against Barrett's Adenocarcinoma in a Mouse Xenograft Model
Suman Kambhampati et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Use of Statin Medications and Risk of Esophageal Adenocarcinoma in Persons with Barrett's Esophagus
Elizabeth D. Kantor et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
Ian L. P. Beales et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Esophageal Adenocarcinoma Incidence in Individuals With Gastroesophageal Reflux: Synthesis and Estimates From Population Studies
Joel H. Rubenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Increasing incidence of Barrett's oesophagus: a population-based study
Helen G. Coleman et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Nonsteroidal Anti-Inflammatory Drugs and Statins Have Chemopreventative Effects in Patients With Barrett's Esophagus
Florine Kastelein et al.
GASTROENTEROLOGY (2011)
Risk of Malignant Progression in Barrett's Esophagus Patients: Results from a Large Population-Based Study
Shivaram Bhat et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
GASTROENTEROLOGY (2010)
A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase)
Sunil A. Sonwalkar et al.
HISTOPATHOLOGY (2010)
Medication Usage and the Risk of Neoplasia in Patients With Barrett's Esophagus
Dang M. Nguyen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Kenneth K. Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease
MB Cook et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Increasing incidence of Barrett's oesophagus in the general population
EM van Soest et al.
GUT (2005)
Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center
M van Blankenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence
H Pohl et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
E Montgomery et al.
HUMAN PATHOLOGY (2001)
Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study
E Montgomery et al.
HUMAN PATHOLOGY (2001)